eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | ankylosing spondylitis |
| Comorbidity | C0021390|inflammatory bowel diseases |
| Sentences | 1 |
| PubMedID- 24714167 | [post-meeting note: since the presentation of these studies during the congress, ct-p13 molecule was approved and licensed in uk and eu under remsima® or inflectra® trade names in rheumatoid arthritis and ankylosing spondylitis indications with extrapolation to inflammatory bowel diseases and psoriasis; remsima® is distributed by celltrion healthcare, and inflectra® by hospira in eu.] |
Page: 1